1-3 of 3
Ioannis Klonizakis
Close
Sort by
Journal Articles

Determination of the Percentage of CML Patients that Achieve Continuous Complete Molecular Response Under Treatment with TKIs and Are Eligible for Participation in a TKI Discontinuation Study

George Georgiou, Maria Roumelioti, Maria Dimou, Danai Palaiologou, Angeliki Stefanou, Efstathia Staikou, Marie-Christine Kyrtsonis, Maria K. Angelopoulou, Theodoros P. Vassilakopoulos, Zacharoula I Galani, MD, Eleni Plata, Eleni Variami, Ioannis Korantzis, Konstantinos Tsatalas, Maria Protopapa, Maria Papaioannou, Gerasimos Pangalis, Theodore Marinakis, Georgios Xanthopoulidis, Vassiliki Pappi, Elissavet Vervesou, Argiris Symeonidis, Charis Matsouka, Konstantinos Anargyrou, Konstantinos Tsionos, Nora Vyniou, Dimitra Gougopoulou, Dimitra Liapi, Dionysis Kolokythopoulos, Paraskevi Roussou, Konstantina Reppa, Eleni Poumbouridou, Eirini Katodritou, Ioannis Klonizakis, Panayiotis Panayiotidis
Journal: Blood
Blood (2011) 118 (21): 4446.
https://doi.org/10.1182/blood.V118.21.4446.4446
Published: 2011
Journal Articles

CD59 Deficient Granulocytes in High Risk Groups of Myelodysplastic Syndromes (MDS).

Georgia Kaiafa, Vasiliki Tsavdaridou, Athanasios Papadopoulos, Christos Savopoulos, Apostolos Hatzitolios, Zoi Saouli, Georgios Zioutas, Ioannis Klonizakis
Journal: Blood
Blood (2004) 104 (11): 4717.
https://doi.org/10.1182/blood.V104.11.4717.4717
Published: 2004
Journal Articles

The Expression of Platelet Membrane Glycoproteins in Patients with Myelodysplastic Syndrome (MDS).

Fotios I.F. Girtovitis, MD, Vasilis Papagiannis, Ioannis Klonizakis, Athanasios Papadopoulos, Dimitris Bougiouklis, Afroditi A.K. Boutou, MD, Pantelis P.E.M. Makris
Journal: Blood
Blood (2004) 104 (11): 4730.
https://doi.org/10.1182/blood.V104.11.4730.4730
Published: 2004